GlaxoSmithKline (GSK) to break up after striking Pfizer joint venture. Drugmaker plans to split in two after spinning off consumer product unit
Lex – GlaxoSmithKline (GSK)/Pfizer: headache remedy. Deal leaves UK pharma group in the driving seat, without a cash acquisition cost
Eleven banks gain approval to join Royal Bank of Scotland Group (RBS) competition scheme. Programme was condition of RBS bailout during the financial crisis
Also by Paul Kettle Kettle
© Vox Markets 2024. All rights reserved.
Follow @VOXmarketsTerms and conditions | Community standards | Compliance | Privacy and cookie policy
Prices and trades are delayed by at least 15 minutes. Vox Markets takes no responsibility for the accuracy of the information within this site. All times quoted are based on the current time in London, UK.
